Skip to main content
. 2020 May 21;18:100. doi: 10.1186/s12957-020-01865-0

Table 5.

Additional biopsies due to findings from CEM

At least one additional biopsy (n = 47) No 34 (72%)
Yes 13 (28%)
Biopsy led to changed treatment (n = 13) No 6 (46%)
Yes 7 (54%)
Additional biopsies per patient 0 34 (72%)
1 9 (19%)
2 2 (4%)
3 2 (4%)
Total number of additional biopsies 19
Outcome from additional biopsies (n = 19) Invasive cancer 6 (32%)
DCIS 3 (16%)
Benign 10 (53%)

CEM contrast-enhanced mammography, DCIS ductal carcinoma in situ